The Beneficial Effects Of early Dexamethasone Administration in Infants and Children with Bacterial Meningitis

New England Journal of Medicine

Volumn 324, Issue 22, 1991, Pages 1525-1531

  Odio, Carla M ^a   Faingezicht, Idis ^a   Paris, Maria ^a   Nassar, Martin ^a   Baltodano, Aristides ^a   Rogers, Jodi ^b   Sáez Llorens, Xavier ^c   Olsen, Kurt D ^c   McCragken, George H ^c  

^a National Children's Hospital   (Costa Rica)

^b Electrophysiology Laboratories ^*  (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; DEXAMETHASONE; PLACEBO; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL MENINGITIS; BRAIN PERFUSION; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS;

EID: 0025876403     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199105303242201     Document Type: Article

References (24)

1. Sáez-Llorens X, Ramilo O, Mustafa M, Mertsola J, McCracken GH Jr. Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr 1990; 116: 671–84.
2. Tunkle AR. Wispelwey B, Scheld WM. Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med 1990; 112: 610–23.
3. Ramilo O, Sáez-Llorens X, Mertsola J, et al. Tumor necrosis factor α/ cachectin and interleukin 1β initiate meningeal inflammation. J Exp Med 1990; 172: 497–507.
4. Syrogiannopoulos G, Olsen KD, Reisch JS, McCracken GH Jr. Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis 1987; 155: 213–9.
5. Tauber MG, Khayam-Bashi H, Sande MA. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985; 151: 528–34.
6. Kadurugamuwa JL, Hengstler B, Zak O. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis 1989; 159: 26–34.
7. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebo-controlled trials. N Engl J Med 1988; 319: 964–71.
8. Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis 1989; 160: 818–25.
9. Fischer H, Tomasz A. Production and release of peptidoglycan and wall teichoic acid polymers in pneumococci treated with beta-lactam antibiotics. J Bacteriol 1984; 157: 507–13.
10. Tauber MG, Shibl AM, Haekbarth CJ, Larrick JW, Sande MA. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis 1987; 156: 456–62.
11. Arditi M, Ables L, Yogev R. Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J Infect Dis 1989; 160: 1005–11.
12. Jennett B, Teasdale G. Aspects of coma after severe head injury. Lancet 1977; 1: 878–81.
13. James HE. Neurological evaluation and support in the child with an acute brain insult. Pediatr Ann 1986; 15: 16–22.
14. Herson VC, Todd JK. Prediction of morbidity in Hemophilus influenzae meningitis. Pediatrics 1977; 59: 35–9.
15. Goitein KJ, Fainmesser P, Sohmer H. Cerebral perfusion pressure and auditory brain-stem responses in childhood CNS diseases. Am J Dis Child 1983; 137: 777–81.
16. Mustafa MM, Lebel MH, Ramilo O, et al. Correlation of interleukin-1β and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 1989; 115: 208–13.
17. Mustafa MM, Ramilo O, Sáez-Llorens X, Olsen K, Magness R, McCracken GH Jr. Cerebrospinal fluid prostaglandins, interleukin-1β, and tumor necrosis factor in bacterial meningitis: clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child 1990; 144: 883–7.
18. McAllister CK, O'Donoghue JM, Beaty HN. Experimental pneumococcal meningitis. II. Characterization and quantitation of the inflammatory process. J Infect Dis 1975; 132: 355–60.
19. Saukkonen K, Sande S, Cioffe C, et al. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 1990; 171: 439–48.
20. Mins RA, Engleman HM, Stirling H. Cerebrospinal fluid pressure in pyogenic meningitis. Arch Dis Child 1989; 64: 814–20.
21. McMenamin JB, Volpe JJ. Bacterial meningitis in infancy: effects on intracranial pressure and cerebral blood flow velocity. Neurology 1984; 34: 500–4.
22. McCracken GH Jr, Lebel MH. Dexamethasone therapy for bacterial meningitis in infants and children. Am J Dis Child 1989; 143: 287–9.
23. Odio CM, Faingezicht I, Salas JL, Guevara J, Mohs E, McCracken GH Jr. Cefotaxime vs. conventional therapy for the treatment of bacterial meningitis of infants and children. Pediatr Infect Dis J 1986; 5: 402–7.
24. Schaad UB, Suter S, Gianella-Borradori A, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med 1990; 322: 141–7.